🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › New York › Buffalo

Qorannoo klinikaalii Kansarii Ovarii Buffalo, NY keessatti

Qorannoo 13 Kansarii Ovarii f Buffalo fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Roswell Park Cancer Institute, Buffalo
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Roswell Park Cancer Institute IDS, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Roswell Park Cancer Institute, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park Comprehensive Cancer Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07489287

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park Comprehensive Cancer Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06774963

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Roswell Park Cancer Institute, Buffalo
Umuriin 18 fi ol · Dubartoota · Haaromfame 14-Hag-2026 · NCT05231122

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park Comprehensive Care Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07444814

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Roswell Park Cancer Institute, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Elb-2026 · NCT05735080

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

Namoota walitti qabaa jiraSadarkaa 2
  • Roswell Park Cancer Institute, Buffalo
Umuriin 18 fi ol · Dubartoota · Haaromfame 23-Bit-2026 · NCT04919629

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park, Buffalo
Umuriin 18 fi ol · Dubartoota · Haaromfame 18-Mud-2025 · NCT07030907

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Buffalo
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Buffalo keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.